Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of IMC-11F8 in Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: March 16, 2010
Last updated: November 5, 2013
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)